Skip to content

Application of esketamine or sufentanil combined with propofol in anesthesia induction for elective surgery in elderly patients

Application of different anesthesia induction schemes in elective surgery in elderly patients

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400094676
Enrollment
Unknown
Registered
2024-12-26
Start date
2024-12-27
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Elderly patients who require general anesthesia and endotracheal intubation

Interventions

S group:Remimazolam 0.2mg/kg + sufentanil 0.4ug/kg + propofol 2mg/kg
E group:Remimazolam 0.2mg/kg + esketamine 0.5mg/kg + propofol 2mg/kg + lidocaine 1.5mg/kg

Sponsors

Jiangxi Provincial People's Hospital (The First Affiliated Hospital of Nanchang Medical College)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Patient age: 60-80 years old, gender is not limited, body mass index (BMI) is 18.5-25kg/m²; (2) Patients are awake before surgery, elective surgery and anesthesia requires general anesthesia with endotracheal intubation; (3) American Society of Anesthesiologists (ASA) grade I-III and Mallampati airway grade I-II before surgery; (4) No serious heart, lung, brain and other important organ diseases, no obvious abnormalities in liver and kidney function; (5) Clearly understand the research content of this study before surgery and voluntarily participate, and sign the informed consent form;

Exclusion criteria

Exclusion criteria: (1) Patients with severe heart, lung, liver, or kidney dysfunction or severe cardiovascular and cerebrovascular diseases; (2) Patients with high-grade atrioventricular block who need to be implanted with a pacemaker; (3) Patients with sinus tachycardia or severe arrhythmia; (4) Patients with poorly controlled or untreated hypertension (resting systolic/diastolic blood pressure >180/100 mmHg); (5) Patients with known allergies to the anesthetics used in this study or with a history of severe allergies; (6) Patients who have long-term use of nonsteroidal anti-inflammatory drugs, narcotic analgesics, or sedatives; (7) Patients with mental illness and consciousness; (8) Patients who have taken hormone drugs before surgery;

Design outcomes

Primary

MeasureTime frame
mean arterial pressure, MAP;Bispectral Index (BIS);

Secondary

MeasureTime frame
Blood gas analysis (blood sugar, blood lactate);Number of cases of additional propofol during intubation;Use of vasoactive drugs;Incidence of adverse events (choking, injection pain, hypertension, hypotension, tachycardia, bradycardia, nausea and vomiting, delayed awakening);

Countries

China

Contacts

Public ContactXu Jinhui

Jiangxi Provincial People's Hospital (The First Affiliated Hospital of Nanchang Medical College)

mzkxjh@163.com+86 152 7916 7137

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026